News

The Wall Street Journal: CDC advisers recommend Pfizer COVID-19 booster shot for kids ages 5 to 11

0

Experts advising the Centers for Disease Control and Prevention on vaccines recommended that children age 5 to 11 receive the newly authorized COVID-19 booster shot from Pfizer Inc.
PFE,
+0.50%

and BioNTech SE
BNTX,
+6.88%
.

The panel’s 11 to 1 vote, with one abstention, on Thursday will guide the nation’s doctors, schools and local policy makers advising parents of the 28 million U.S. children in the age group.

The Food and Drug Administration earlier this week cleared the third Pfizer-BioNTech shot for the school-age children, to be given five months after the second dose. The extra dose is one-third the amount that those 12 years old and above receive.

An expanded version of this report appears at WSJ.com.

Top stories from WSJ

More Subprime Borrowers Are Missing Loan Payments

This Could Be a Lost Decade for Stocks

Earnings Results: Ross Stores is latest retailer to disappoint Wall Street, stock falls 16%

Previous article

: Swiss running shoe company On Holding runs with premium pricing despite inflation

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News